| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6200966 | Ophthalmology | 2015 | 9 Pages |
Abstract
In this study, BCVA was improved up to 5 years after FMT. Foveal RPE atrophy, CNV recurrence, and PVR carried a worse prognosis. In patients who are unlikely to benefit from VEGF inhibitors, FMT can be considered for second eyes with neovascular AMD.
Keywords
CNVAMDRPEPerfluorocarbon liquidBCVAlogMARSD OCTFMTChoroidal neovascularizationretinal pigment epitheliumbest-corrected visual acuitySpectral-domain optical coherence tomographyage-related macular degenerationPVRVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)logarithm of the minimum angle of resolutionodds ratioProliferative vitreoretinopathy
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Saskia H.M. MD, Antonio MD, Laura MD, Massimo PhD, Grazia MD,